Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation
Top Cited Papers
Open Access
- 1 January 2006
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (1) , 75-80
- https://doi.org/10.1136/bjo.2005.073643
Abstract
Background/aims: There is evidence that smoking is a risk factor for age related macular degeneration (AMD). However, not all studies have demonstrated this association and several key questions about the role of smoking in AMD have still to be determined. The aim of this study was to further investigate this relation for both choroidal neovascularisation (CNV) and geographic atrophy (GA). Methods: To investigate the relation between smoking and the risk of developing age related macular degeneration (AMD) in white people, 435 cases with end stage AMD were compared with 280 controls. All subjects had graded stereoscopic colour fundus photography and AMD was defined as the presence of GA or CNV. Smoking history was assessed using multiple parameters in a detailed questionnaire. Results: Comparison of current and former smokers with non-smokers was consistent with smoking being a risk factor for AMD but did not reach statistical significance. There was a strong association between AMD and pack years of cigarette smoking (p = 0.002), the odds ratio increasing with the amount smoked; for subjects with more than 40 pack years of smoking the odds ratio was 2.75 (95% CI 1.22 to 6.20) compared with non-smokers. Both types of AMD showed a similar relation; smoking more than 40 pack years of cigarettes was associated with an odds ratio of 3.43 (95% CI 1.28 to 9.20) for GA and 2.49 (95% CI 1.06 to 5.82) for CNV. Stopping smoking was associated with reduced odds of AMD and the risk in those who had not smoked for over 20 years was comparable to non-smokers. The risk profile was similar for males and females. Passive smoking exposure was associated with an increased risk of AMD (OR 1.87; 95% CI 1.03 to 3.40) in non-smokers. Conclusions: The authors have demonstrated a strong association between the risk of both GA and CNV and pack years of cigarette smoking. This provides support for a causal relation between smoking and AMD. They also show an increased risk for AMD in non-smokers exposed to passive smoking. Stopping smoking appears to reduce the risk of developing AMD.Keywords
This publication has 39 references indexed in Scilit:
- Strong Association of the Y402H Variant in Complement Factor H at 1q32 with Susceptibility to Age-Related Macular DegenerationAmerican Journal of Human Genetics, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Complement Factor H Variant Increases the Risk of Age-Related Macular DegenerationScience, 2005
- Complement Factor H Polymorphism and Age-Related Macular DegenerationScience, 2005
- Oxidative Stress Affects the Junctional Integrity of Retinal Pigment Epithelial CellsInvestigative Opthalmology & Visual Science, 2004
- Is calculating pack‐years retrospectively a valid method to estimate life‐time tobacco smoking? A comparison between prospectively calculated pack‐years and retrospectively calculated pack‐yearsAddiction, 2001
- Risk factors for age-related macular degenerationOphthalmology, 2001
- Age-related maculopathy in a multiracial United States populationOphthalmology, 1999
- Influence of Nicotine and Cotinine on Retinal Phospholipase A2 and its Significance to Macular FunctionJournal of Ocular Pharmacology and Therapeutics, 1998
- Is the incidence of registrable age-related macular degeneration increasing?British Journal of Ophthalmology, 1996